Anika Therapeutics, Inc.ANIKNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
1.77
↓ 56% below average
Average (9y)
4.04
Historical baseline
Range
High:5.94
Low:1.77
CAGR
-10.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.77 | -26.4% |
| 2023 | 2.41 | -27.0% |
| 2022 | 3.30 | +10.2% |
| 2021 | 2.99 | -31.5% |
| 2020 | 4.37 | -16.1% |
| 2019 | 5.21 | +38.8% |
| 2018 | 3.75 | -34.7% |
| 2017 | 5.75 | -3.2% |
| 2016 | 5.94 | +20.4% |
| 2015 | 4.94 | - |